Aptevo Therapeutics Inc.APVONASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
5.71%
↑ 104% vs avg
Percentile
P54
Within normal range
Streak
2 qtr
Consecutive growthAccelerating
Average
-147.79%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 5.71% |
| Q2 2025 | -7.88% |
| Q1 2025 | -14.17% |
| Q4 2024 | -10.28% |
| Q3 2024 | 15.13% |
| Q2 2024 | 7.49% |
| Q1 2024 | -26.61% |
| Q4 2023 | 15.82% |
| Q3 2023 | -29.92% |
| Q2 2023 | -205.19% |
| Q1 2023 | 176.88% |
| Q4 2022 | 13.88% |
| Q3 2022 | -124.63% |
| Q2 2022 | 40.00% |
| Q1 2022 | -31.88% |
| Q4 2021 | 25.98% |
| Q3 2021 | -3.74% |
| Q2 2021 | 32.66% |
| Q1 2021 | -22.55% |
| Q4 2020 | 17.11% |
| Q3 2020 | -59.44% |
| Q2 2020 | 58.54% |
| Q1 2020 | -119.12% |
| Q4 2019 | 32.43% |
| Q3 2019 | 52.50% |
| Q2 2019 | -14.79% |
| Q1 2019 | -89.85% |
| Q4 2018 | 34.58% |
| Q3 2018 | 30.36% |
| Q2 2018 | 5.73% |
| Q1 2018 | -10.10% |
| Q4 2017 | -855.45% |
| Q3 2017 | 87.10% |
| Q2 2017 | -4.02% |
| Q1 2017 | -80.45% |
| Q4 2016 | -4873.88% |
| Q3 2016 | 99.16% |
| Q2 2016 | -13.02% |
| Q1 2016 | -83.67% |
| Q4 2015 | 17.86% |